{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:52:30Z","timestamp":1760853150116,"version":"3.32.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.pbb.2005.09.006","type":"journal-article","created":{"date-parts":[[2005,10,11]],"date-time":"2005-10-11T11:22:58Z","timestamp":1129029778000},"page":"361-372","source":"Crossref","is-referenced-by-count":36,"title":["KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia"],"prefix":"10.1016","volume":"82","author":[{"given":"Woo-Kyu","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daeyoung","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heeyeong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Young","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ae Nim","family":"Pae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Il","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hun Yeong","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Yang","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2005.09.006_bib1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/1097-4547(20000915)61:6<674::AID-JNR11>3.0.CO;2-F","article-title":"In vitro autoradiography of serotonin 5-HT2A\/2C receptor-activated G protein: guanosine-5\u2032(-(gamma-[35S]thio)triphosphate binding in rat brain","volume":"61","author":"Adlersberg","year":"2000","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pbb.2005.09.006_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-2999(94)90335-2","article-title":"Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat","volume":"260","author":"Ahlenius","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2005.09.006_bib3","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0028-3908(99)00224-5","article-title":"PD 158771, a potential antipsychotic agent with D2\/D3 partial agonist and 5-HT1A agonist actions: I. Neurochemical effects","volume":"39","author":"Akunne","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2005.09.006_bib4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0301-0082(89)90008-7","article-title":"Neuroendocrine regulation of prolactin release","volume":"33","author":"Ben-Jonathan","year":"1989","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pbb.2005.09.006_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0028-3908(98)00213-5","article-title":"Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice","volume":"38","author":"Boulay","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2005.09.006_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archpsyc.1992.01820030038005","article-title":"Gating and habituation of the startle reflex in schizophrenic patients","volume":"49","author":"Braff","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2005.09.006_bib7","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1476-5381.1993.tb13520.x","article-title":"The glycine\/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents","volume":"108","author":"Bristow","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2005.09.006_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/(SICI)1098-2396(20000615)36:4<297::AID-SYN6>3.0.CO;2-M","article-title":"Dynamic dopamine receptor interactions in the core and shell of nucleus accumbens differentially coordinate the expression of unconditioned motor behaviors","volume":"36","author":"Canales","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2005.09.006_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0893-133X(88)90012-7","article-title":"The current status of the dopamine hypothesis of schizophrenia","volume":"1","author":"Carlsson","year":"1988","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2005.09.006_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00213-002-1132-0","article-title":"Effects of the D3 dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and food-restricted rats","volume":"163","author":"Carr","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2005.09.006_bib11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0091-3057(97)00442-5","article-title":"Pharmacological characterization of PD 152255, a novel dimeric benzimidazole dopamine D3 antagonist","volume":"59","author":"Corbin","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2005.09.006_bib12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/257405a0","article-title":"Rapid and dissociated changes in sensitivities of different dopamine receptors in mouse brain","volume":"257","author":"Costentin","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2005.09.006_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02245588","article-title":"5-HT1A receptor agonists: recent developments and controversial issues","volume":"121","author":"De Vry","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2005.09.006_bib14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jps.3030460322","article-title":"Pharmacological activity of a series of basic esters mono and dialkyl malonic acid","volume":"46","author":"Dunham","year":"1957","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.pbb.2005.09.006_bib15","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1046\/j.1460-9568.2002.01948.x","article-title":"The role of hippocampal dopamine receptors in prepulse inhibition","volume":"15","author":"Ellenbroek","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pbb.2005.09.006_bib16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0014-2999(84)90404-7","article-title":"The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity","volume":"104","author":"Freeman","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2005.09.006_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(85)90178-5","article-title":"Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system","volume":"116","author":"French","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2005.09.006_bib18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1469-8986.1975.tb01284.x","article-title":"The more or less startling effects of weak prestimulation","volume":"12","author":"Graham","year":"1975","journal-title":"Psychophysiology"},{"key":"10.1016\/j.pbb.2005.09.006_bib19","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1097\/00002826-199501001-00015","article-title":"Localization, regulation, and role of the dopamine D3 receptor are distinct from those of the D2 receptor","volume":"18","author":"Griffon","year":"1995","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pbb.2005.09.006_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0773.1990.tb01600.x","article-title":"Amperozide, a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behavior","volume":"66","author":"Gustafsson","year":"1990","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.pbb.2005.09.006_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0014-2999(95)00624-9","article-title":"R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens","volume":"287","author":"Ichikawa","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2005.09.006_bib22","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2005.09.006_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2005.09.006_bib24","first-page":"551","article-title":"Nitric oxide mediation of cocaine-induced dopaminergic behaviors: ambulation-accelerating activity, reverse tolerance and conditioned place preference in mice","volume":"275","author":"Kim","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.09.006_bib25","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/0024-3205(96)00109-9","article-title":"Inhibition by noncompetitive NMDA receptor antagonists of apomorphine-induced climbing behavior in mice","volume":"58","author":"Kim","year":"1996","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2005.09.006_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0014-2999(01)01011-1","article-title":"5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential","volume":"420","author":"Koek","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2005.09.006_bib27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0028-3908(03)00145-X","article-title":"The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade","volume":"45","author":"Leriche","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2005.09.006_bib28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/archneurpsyc.1959.02340150095011","article-title":"Study of a new schizophrenomimetic drug; sernyl","volume":"81","author":"Luby","year":"1959","journal-title":"Arch Neurol Psychiatry"},{"key":"10.1016\/j.pbb.2005.09.006_bib29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s002130050501","article-title":"Selective dopamine D4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibition","volume":"135","author":"Mansbach","year":"1998","journal-title":"Psychoparmacology (Berl)"},{"key":"10.1016\/j.pbb.2005.09.006_bib30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s002130050922","article-title":"The effects of dopamine D2 and D3 antagonists on spontaneous motor activity and morphine-induced hyperactivity in male mice","volume":"143","author":"Manzanedo","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2005.09.006_bib31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0303-7207(84)90037-6","article-title":"Dopaminergic inhibition of adenylate cyclase correlates with high affinity agonist binding to anterior pituitary D2 dopamine receptors","volume":"36","author":"McDonald","year":"1984","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.pbb.2005.09.006_bib32","first-page":"64","article-title":"Role of serotonin in the action of a typical antipsychotic drugs","volume":"3","author":"Meltzer","year":"1995","journal-title":"Clin Neurosci"},{"key":"10.1016\/j.pbb.2005.09.006_bib33","first-page":"1392","article-title":"Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist","volume":"279","author":"Merchant","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.09.006_bib34","first-page":"853","article-title":"Improving the treatment of schizophrenia: focus on serotonin 5-HT1A receptors","volume":"295","author":"Millan","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.09.006_bib35","first-page":"885","article-title":"Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy","volume":"275","author":"Millan","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.09.006_bib36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-3565(24)37777-8","article-title":"S18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2,3b]pyridine) and raclopride","volume":"287","author":"Millan","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.09.006_bib37","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0022-3565(24)37732-8","article-title":"S16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin 5-HT1A agonist properties: II. Functional profile in comparison to clozapine and haloperidol","volume":"286","author":"Millan","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.09.006_bib38","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0022-3565(24)39333-4","article-title":"S33084, a novel, potent, selective, and competitive antagonist at dopamine D3-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626","volume":"293","author":"Millan","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.09.006_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF01244915","article-title":"Effects of dizocipline (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localizaton","volume":"91","author":"Murase","year":"1993","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pbb.2005.09.006_bib40","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0026-895X(24)12183-9","article-title":"G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: a guanosine-5\u2032-O-(3-[35S]thio)-triphosphate binding and antibody study","volume":"55","author":"Newman-Tancredi","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pbb.2005.09.006_bib41","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00210-003-0788-2","article-title":"Comparison of hippocampal G protein activation by 5-HT1A receptor agonists and the atypical antipsychotics clozapine and S16924","volume":"368","author":"Newman-Tancredi","year":"2003","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pbb.2005.09.006_bib42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0893-133X(95)00156-8","article-title":"Inverse agonism at dopamine D2 receptors. Haloperidol-induced prolactin release from GH4C1 cells transfected with the human D2 receptor is antagonized by R(\u2212)-n-propylnorapomorphine, raclopride, and phenoxybenzamine","volume":"15","author":"Nilsson","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2005.09.006_bib43","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0014-2999(84)90567-3","article-title":"Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain","volume":"102","author":"Ogren","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2005.09.006_bib44","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/S0024-3205(99)00476-2","article-title":"A selective dopamine D4 receptor antagonist, NRA0160: a preclinical neuropharmacological profile","volume":"65","author":"Okuyama","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2005.09.006_bib45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-2999(94)90404-9","article-title":"Locomotor activation induced by MK-801 in the rat: postsynaptic interaction with dopamine receptors in the ventral stratum","volume":"251","author":"Ouagazzal","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2005.09.006_bib46","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(78)90414-4","article-title":"Behavioral despair in rats and mice: strain differences and the effects of imipramine","volume":"51","author":"Porsolt","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2005.09.006_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00634146","article-title":"Climbing behaviour induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum","volume":"50","author":"Protais","year":"1976","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2005.09.006_bib48","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S0022-3565(24)39184-0","article-title":"Pharmacological actions of a novel, high-affinity, and selective human dopamine D3 receptor antagonist, SB-277011-A","volume":"294","author":"Reavill","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.09.006_bib49","first-page":"486","article-title":"5-hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex","volume":"263","author":"Rigdon","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.09.006_bib50","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(97)81951-6","article-title":"Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation","volume":"338","author":"Rollema","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2005.09.006_bib51","first-page":"1239","article-title":"Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents","volume":"275","author":"Sautel","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.09.006_bib52","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0165-6147(94)90323-9","article-title":"Dopamine receptor pharmacology","volume":"15","author":"Seeman","year":"1994","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2005.09.006_bib53","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1469-8986.1992.tb02004.x","article-title":"Reflex modification in psychosis-prone young adults","volume":"29","author":"Simons","year":"1992","journal-title":"Psychophysiology"},{"key":"10.1016\/j.pbb.2005.09.006_bib54","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/285355a0","article-title":"Phencyclidinne","volume":"285","author":"Snyder","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2005.09.006_bib55","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0893-133X(88)90016-4","article-title":"Psychogenic drugs as models of schizophrenia","volume":"1","author":"Snyder","year":"1988","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2005.09.006_bib56","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor D3 as a target for neuroleptics","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2005.09.006_bib57","first-page":"224","article-title":"Localization and function of the D3 dopamine receptor","volume":"42","author":"Sokoloff","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.pbb.2005.09.006_bib58","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00008877-199809000-00008","article-title":"Dopamine agonist-induced hypothermia and disruption of prepulse inhibition: evidence for a role of D3 receptors?","volume":"9","author":"Varty","year":"1998","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2005.09.006_bib59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF01244979","article-title":"The dopamine D3 receptor: a postsynaptic receptor inhibitory on rat locomotor activity","volume":"94","author":"Waters","year":"1993","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pbb.2005.09.006_bib60","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0893-133X(00)00150-0","article-title":"WAY 100135, an antagonist of 5-HT1A serotonin receptors, attenuates psychotomimetic effects of MK-801","volume":"23","author":"Wedzony","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2005.09.006_bib61","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00008877-200305000-00005","article-title":"A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine","volume":"14","author":"Weiner","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2005.09.006_bib62","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00008877-199308000-00017","article-title":"Behavioral sensitization to MK-801 (dizocilpine): neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system","volume":"4","author":"Wolf","year":"1993","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2005.09.006_bib63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1749-6632.1998.tb08219.x","article-title":"Unraveling dopamine D3 receptor function in response to psychostimulants using a genetic approach","volume":"844","author":"Xu","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pbb.2005.09.006_bib64","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/(SICI)1098-2396(19990301)31:3<210::AID-SYN6>3.0.CO;2-0","article-title":"Dopamine D3 receptor mutant and wild-type mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists","volume":"31","author":"Xu","year":"1999","journal-title":"Synapse"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305705003072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305705003072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T22:01:23Z","timestamp":1736028083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305705003072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0091305705003072"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2005.09.006","relation":{},"ISSN":["0091-3057"],"issn-type":[{"type":"print","value":"0091-3057"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}